Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Neoplasms 6 Prostatic Neoplasms 5 Anxiety Disorders 5 Leukemia 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Neoplasms, Plasma Cell 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma 3 Fatigue 3 Depression 3 Colorectal Neoplasms 3 Rectal Neoplasms 2 Primary Myelofibrosis 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Gastrointestinal Stromal Tumors 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Anus Neoplasms 2 cyclopia sequence 1 Vulvar Neoplasms 1 Vomiting 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1

Interventions

Cetuximab 3 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2 Cisplatin 2 capmatinib 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Adjuvant 1 Radiotherapy 1 Proflavine 1 Modafinil 1 Minocycline 1 Laryngectomy 1 Interviews as Topic 1 Emulsions 1 Chemoradiotherapy 1 Bupropion 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Laryngeal Diseases × Surveys and Questionnaires × Clear all

NCT01647477 2026-03-13

DEREDIA

Centre Oscar Lambret

Phase NA Terminated

Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡